Alaunos Therapeutics's total assets for Q3 2024 were $3.55M, a decrease of -24.11% from the previous quarter. TCRT total liabilities were $826.00K for the fiscal quarter, a -8.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.